HEADER TRANSFERASE/INHIBITOR 07-SEP-23 8U37 TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PKC ALPHA (D463N, TITLE 2 V568I, S657E) IN COMPLEX WITH NVP-CJL037 AT 2.48-A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C ALPHA TYPE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 320-672; COMPND 5 SYNONYM: PKC-A,PKC-ALPHA; COMPND 6 EC: 2.7.11.13; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PRKCA, PKCA, PRKACA; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.J.ROMANOWSKI,J.LAM,M.VISSER REVDAT 2 31-JAN-24 8U37 1 JRNL REVDAT 1 24-JAN-24 8U37 0 JRNL AUTH M.VISSER,J.P.N.PAPILLON,M.LUZZIO,M.J.LAMARCHE,J.FAN, JRNL AUTH 2 W.MICHAEL,D.WANG,A.ZHANG,C.STRAUB,S.MATHIEU,M.KATO, JRNL AUTH 3 M.PALERMO,C.CHEN,T.RAMSEY,C.JOUD,R.BARRETT,A.VATTAY,R.GUO, JRNL AUTH 4 A.BRIC,F.CHUNG,G.LIANG,M.J.ROMANOWSKI,J.LAM,S.THOHAN, JRNL AUTH 5 F.ATASSI,A.WYLIE,V.G.COOKE JRNL TITL DISCOVERY OF DAROVASERTIB (NVP-LXS196), A PAN-PKC INHIBITOR JRNL TITL 2 FOR THE TREATMENT OF METASTATIC UVEAL MELANOMA. JRNL REF J.MED.CHEM. V. 67 1447 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38198520 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02002 REMARK 2 REMARK 2 RESOLUTION. 2.48 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.48 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.66 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 12967 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 633 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.6600 - 4.2400 0.98 2530 118 0.1744 0.2076 REMARK 3 2 4.2400 - 3.3700 0.99 2485 125 0.2019 0.2097 REMARK 3 3 3.3700 - 2.9400 0.99 2424 133 0.2708 0.3412 REMARK 3 4 2.9400 - 2.6700 0.99 2472 117 0.3225 0.4267 REMARK 3 5 2.6700 - 2.4800 0.98 2423 140 0.3596 0.4370 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.398 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.388 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.43 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 85.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2725 REMARK 3 ANGLE : 1.412 3690 REMARK 3 CHIRALITY : 0.075 387 REMARK 3 PLANARITY : 0.012 474 REMARK 3 DIHEDRAL : 7.398 360 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 24.1208 -0.5017 16.4102 REMARK 3 T TENSOR REMARK 3 T11: 0.4816 T22: 0.4509 REMARK 3 T33: 0.4437 T12: -0.0287 REMARK 3 T13: -0.0060 T23: 0.0204 REMARK 3 L TENSOR REMARK 3 L11: 0.4543 L22: 1.6100 REMARK 3 L33: 1.4736 L12: 0.4814 REMARK 3 L13: -0.2124 L23: -0.5084 REMARK 3 S TENSOR REMARK 3 S11: -0.0501 S12: -0.0942 S13: 0.0535 REMARK 3 S21: 0.3761 S22: -0.0273 S23: 0.0437 REMARK 3 S31: -0.1128 S32: 0.0387 S33: -0.0003 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8U37 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1000277267. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-FEB-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13022 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.480 REMARK 200 RESOLUTION RANGE LOW (A) : 52.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.48 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.37200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: PDB ENTRY 3IW4 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS, PH 5.5, 18% PEG3350, REMARK 280 0.2 M MAGNESIUM CHLORIDE, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 53.92550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 22.20500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 53.92550 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 22.20500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 319 REMARK 465 PRO A 320 REMARK 465 SER A 321 REMARK 465 GLU A 322 REMARK 465 ASP A 323 REMARK 465 ARG A 324 REMARK 465 LYS A 325 REMARK 465 GLN A 326 REMARK 465 PRO A 327 REMARK 465 SER A 328 REMARK 465 ASN A 329 REMARK 465 ASN A 330 REMARK 465 LEU A 331 REMARK 465 VAL A 618 REMARK 465 CYS A 619 REMARK 465 GLY A 620 REMARK 465 LYS A 621 REMARK 465 GLY A 622 REMARK 465 ALA A 623 REMARK 465 GLU A 624 REMARK 465 ASN A 625 REMARK 465 PHE A 626 REMARK 465 ASP A 627 REMARK 465 LYS A 628 REMARK 465 PHE A 629 REMARK 465 PHE A 630 REMARK 465 THR A 631 REMARK 465 ARG A 632 REMARK 465 ILE A 667 REMARK 465 LEU A 668 REMARK 465 GLN A 669 REMARK 465 SER A 670 REMARK 465 ALA A 671 REMARK 465 VAL A 672 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A 550 CG1 - CB - CG2 ANGL. DEV. = -14.3 DEGREES REMARK 500 LYS A 604 CA - CB - CG ANGL. DEV. = 18.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 333 18.30 -151.66 REMARK 500 ASP A 481 85.00 71.84 REMARK 500 PRO A 639 150.65 -49.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8UAK RELATED DB: PDB DBREF 8U37 A 320 672 UNP P17252 KPCA_HUMAN 320 672 SEQADV 8U37 GLY A 319 UNP P17252 EXPRESSION TAG SEQADV 8U37 ASN A 463 UNP P17252 ASP 463 ENGINEERED MUTATION SEQADV 8U37 ILE A 568 UNP P17252 VAL 568 ENGINEERED MUTATION SEQADV 8U37 GLU A 657 UNP P17252 SER 657 ENGINEERED MUTATION SEQRES 1 A 354 GLY PRO SER GLU ASP ARG LYS GLN PRO SER ASN ASN LEU SEQRES 2 A 354 ASP ARG VAL LYS LEU THR ASP PHE ASN PHE LEU MET VAL SEQRES 3 A 354 LEU GLY LYS GLY SER PHE GLY LYS VAL MET LEU ALA ASP SEQRES 4 A 354 ARG LYS GLY THR GLU GLU LEU TYR ALA ILE LYS ILE LEU SEQRES 5 A 354 LYS LYS ASP VAL VAL ILE GLN ASP ASP ASP VAL GLU CYS SEQRES 6 A 354 THR MET VAL GLU LYS ARG VAL LEU ALA LEU LEU ASP LYS SEQRES 7 A 354 PRO PRO PHE LEU THR GLN LEU HIS SER CYS PHE GLN THR SEQRES 8 A 354 VAL ASP ARG LEU TYR PHE VAL MET GLU TYR VAL ASN GLY SEQRES 9 A 354 GLY ASP LEU MET TYR HIS ILE GLN GLN VAL GLY LYS PHE SEQRES 10 A 354 LYS GLU PRO GLN ALA VAL PHE TYR ALA ALA GLU ILE SER SEQRES 11 A 354 ILE GLY LEU PHE PHE LEU HIS LYS ARG GLY ILE ILE TYR SEQRES 12 A 354 ARG ASN LEU LYS LEU ASP ASN VAL MET LEU ASP SER GLU SEQRES 13 A 354 GLY HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS GLU SEQRES 14 A 354 HIS MET MET ASP GLY VAL THR THR ARG TPO PHE CYS GLY SEQRES 15 A 354 THR PRO ASP TYR ILE ALA PRO GLU ILE ILE ALA TYR GLN SEQRES 16 A 354 PRO TYR GLY LYS SER VAL ASP TRP TRP ALA TYR GLY VAL SEQRES 17 A 354 LEU LEU TYR GLU MET LEU ALA GLY GLN PRO PRO PHE ASP SEQRES 18 A 354 GLY GLU ASP GLU ASP GLU LEU PHE GLN SER ILE MET GLU SEQRES 19 A 354 HIS ASN VAL SER TYR PRO LYS SER LEU SER LYS GLU ALA SEQRES 20 A 354 VAL SER ILE CYS LYS GLY LEU MET THR LYS HIS PRO ALA SEQRES 21 A 354 LYS ARG LEU GLY CYS GLY PRO GLU GLY GLU ARG ASP VAL SEQRES 22 A 354 ARG GLU HIS ALA PHE PHE ARG ARG ILE ASP TRP GLU LYS SEQRES 23 A 354 LEU GLU ASN ARG GLU ILE GLN PRO PRO PHE LYS PRO LYS SEQRES 24 A 354 VAL CYS GLY LYS GLY ALA GLU ASN PHE ASP LYS PHE PHE SEQRES 25 A 354 THR ARG GLY GLN PRO VAL LEU TPO PRO PRO ASP GLN LEU SEQRES 26 A 354 VAL ILE ALA ASN ILE ASP GLN SER ASP PHE GLU GLY PHE SEQRES 27 A 354 GLU TYR VAL ASN PRO GLN PHE VAL HIS PRO ILE LEU GLN SEQRES 28 A 354 SER ALA VAL MODRES 8U37 TPO A 497 THR MODIFIED RESIDUE MODRES 8U37 TPO A 638 THR MODIFIED RESIDUE HET TPO A 497 11 HET TPO A 638 11 HET V5U A 701 36 HET MG A 702 1 HETNAM TPO PHOSPHOTHREONINE HETNAM V5U (6M)-3-AMINO-N-{4-[(3R,4S)-4-AMINO-3-METHOXYPIPERIDIN- HETNAM 2 V5U 1-YL]PYRIDIN-3-YL}-6-[3-(TRIFLUOROMETHOXY)PYRIDIN-2- HETNAM 3 V5U YL]PYRAZINE-2-CARBOXAMIDE HETNAM MG MAGNESIUM ION HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 2 V5U C22 H23 F3 N8 O3 FORMUL 3 MG MG 2+ FORMUL 4 HOH *7(H2 O) HELIX 1 AA1 LYS A 335 THR A 337 5 3 HELIX 2 AA2 LYS A 372 ASP A 379 1 8 HELIX 3 AA3 ASP A 380 LEU A 393 1 14 HELIX 4 AA4 ASP A 424 GLN A 431 1 8 HELIX 5 AA5 LYS A 436 ARG A 457 1 22 HELIX 6 AA6 THR A 501 ILE A 505 5 5 HELIX 7 AA7 ALA A 506 ALA A 511 1 6 HELIX 8 AA8 LYS A 517 GLY A 534 1 18 HELIX 9 AA9 ASP A 542 HIS A 553 1 12 HELIX 10 AB1 SER A 562 MET A 573 1 12 HELIX 11 AB2 HIS A 576 ARG A 580 5 5 HELIX 12 AB3 GLU A 586 GLU A 593 1 8 HELIX 13 AB4 HIS A 594 ARG A 598 5 5 HELIX 14 AB5 ASP A 601 ASN A 607 1 7 HELIX 15 AB6 ASP A 641 ALA A 646 1 6 HELIX 16 AB7 ASN A 647 ILE A 648 5 2 HELIX 17 AB8 ASP A 649 GLU A 654 5 6 SHEET 1 AA1 6 PHE A 339 GLY A 348 0 SHEET 2 AA1 6 GLY A 351 ARG A 358 -1 O VAL A 353 N GLY A 346 SHEET 3 AA1 6 LEU A 364 LYS A 371 -1 O ILE A 369 N LYS A 352 SHEET 4 AA1 6 ARG A 412 GLU A 418 -1 O LEU A 413 N LEU A 370 SHEET 5 AA1 6 LEU A 403 GLN A 408 -1 N HIS A 404 O VAL A 416 SHEET 6 AA1 6 TYR A 658 VAL A 659 -1 O TYR A 658 N CYS A 406 SHEET 1 AA2 2 VAL A 469 LEU A 471 0 SHEET 2 AA2 2 ILE A 477 ILE A 479 -1 O LYS A 478 N MET A 470 LINK C ARG A 496 N TPO A 497 1555 1555 1.34 LINK C TPO A 497 N PHE A 498 1555 1555 1.33 LINK C LEU A 637 N TPO A 638 1555 1555 1.33 LINK C TPO A 638 N PRO A 639 1555 1555 1.35 LINK O1P TPO A 497 MG MG A 702 1555 1555 2.47 CRYST1 107.851 44.410 84.789 90.00 114.62 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009272 0.000000 0.004249 0.00000 SCALE2 0.000000 0.022517 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012973 0.00000